While the utility of TIMP-2, IGFPB7, and L-FABP for the prediction of AKI within 1–7 days of ADHF onset has been investigated [13,14,15,16,17], no markers have sufficient sensitivity and specificity for routine clinical use, with several studies presenting mixed and inconclusive results [19]. This evidence concerns the gene FABP1 and acute kidney injury.